QL
VKTX icon

Quarry LP’s Viking Therapeutics VKTX Stock Holding History

Quarry LP’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09K Buy
+28
New +$904 ﹤0.01% 1926
2025
Q2 		– Sell
-1,205
Closed -$29.1K – 2086
2025
Q1 		$29.1K Buy
1,205
+1,135
+1,621% +$35.9K 0.01% 1008
2024
Q4 		$2.82K Buy
+70
New +$3.99K ﹤0.01% 1439
2024
Q2 		– Sell
-50
Closed -$4.1K – 2126
2024
Q1 		$4.1K Buy
+50
New +$2.23K ﹤0.01% 1379

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Quarry LP's VKTX Position: Q2 2026 in Review

Quarry LP opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 28 shares worth $1.09K. The stake represents ﹤0.01% of the portfolio and ranks #1926 among its holdings. This is a return to the name: Quarry LP previously reported a position in VKTX as recently as Q1 2025.

Quarry LP first reported a position in VKTX in Q1 2024 and has held it in 4 quarters since. The position peaked at $29.1K in Q1 2025. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Quarry LP held 28 shares of Viking Therapeutics worth $1.09K as of Q2 2026.
  • Viking Therapeutics was a new Quarry LP position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1926 holding.
  • Quarry LP first reported a position in Viking Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • Quarry LP's Viking Therapeutics position peaked at $29.1K in Q1 2025.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.